Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.

Burga LN, Tung NM, Troyan SL, Bostina M, Konstantinopoulos PA, Fountzilas H, Spentzos D, Miron A, Yassin YA, Lee BT, Wulf GM.

Cancer Res. 2009 Feb 15;69(4):1273-8. doi: 10.1158/0008-5472.CAN-08-2954. Epub 2009 Feb 3.

2.

One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis.

Yeung AT, Patel BB, Li XM, Seeholzer SH, Coudry RA, Cooper HS, Bellacosa A, Boman BM, Zhang T, Litwin S, Ross EA, Conrad P, Crowell JA, Kopelovich L, Knudson A.

Cancer Res. 2008 Sep 15;68(18):7579-86. doi: 10.1158/0008-5472.CAN-08-0856.

3.

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Kenny HA, Kaur S, Coussens LM, Lengyel E.

J Clin Invest. 2008 Apr;118(4):1367-79. doi: 10.1172/JCI33775.

4.

BRCA1 regulates human mammary stem/progenitor cell fate.

Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5. doi: 10.1073/pnas.0711613105. Epub 2008 Jan 29.

5.

The DNA damage response: ten years after.

Harper JW, Elledge SJ.

Mol Cell. 2007 Dec 14;28(5):739-45. Review.

6.

Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.

Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF.

Stem Cells. 2008 Feb;26(2):364-71. Epub 2007 Nov 1.

7.

Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

Ince TA, Richardson AL, Bell GW, Saitoh M, Godar S, Karnoub AE, Iglehart JD, Weinberg RA.

Cancer Cell. 2007 Aug;12(2):160-70.

8.

Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.

Li X, Cao X, Li X, Zhang W, Feng Y.

Cancer Sci. 2007 Oct;98(10):1592-6. Epub 2007 Jul 25.

9.

Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection.

Caretti E, Devarajan K, Coudry R, Ross E, Clapper ML, Cooper HS, Bellacosa A.

J Cell Biochem. 2008 Feb 1;103(2):556-63.

PMID:
17546586
10.

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES.

Clin Biochem. 2006 Sep;39(9):879-87. Epub 2006 Jul 20.

PMID:
16925986
11.

bioNMF: a versatile tool for non-negative matrix factorization in biology.

Pascual-Montano A, Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Marqui RD.

BMC Bioinformatics. 2006 Jul 28;7:366.

12.

Transcriptional profiling of mammary gland side population cells.

Behbod F, Xian W, Shaw CA, Hilsenbeck SG, Tsimelzon A, Rosen JM.

Stem Cells. 2006 Apr;24(4):1065-74. Epub 2005 Nov 10.

13.

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. Epub 2005 Sep 30.

14.

Identification of mammaglobin as a novel serum marker for breast cancer.

Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, Aaronson SA, Fleming TP.

Clin Cancer Res. 2005 Sep 15;11(18):6528-35.

15.

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

Moshkovskii SA, Serebryakova MV, Kuteykin-Teplyakov KB, Tikhonova OV, Goufman EI, Zgoda VG, Taranets IN, Makarov OV, Archakov AI.

Proteomics. 2005 Sep;5(14):3790-7.

PMID:
16121334
16.

Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.

Daikoku T, Wang D, Tranguch S, Morrow JD, Orsulic S, DuBois RN, Dey SK.

Cancer Res. 2005 May 1;65(9):3735-44.

17.

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE.

Cancer Sci. 2005 Mar;96(3):183-90.

18.

Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations.

Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA, Yeung AT, Nicolas E, Tsichlis N, Li YS, Linehan WM, Howard S, Campbell KS, Godwin AK, Boman BM, Crowell JA, Kopelovich L, Knudson AG.

Cancer Biol Ther. 2004 Dec;3(12):1313-21. Epub 2004 Dec 9.

PMID:
15662135
19.

Supplemental Content

Support Center